Literature DB >> 22425747

Ectopic expression of a T-box transcription factor, eomesodermin, renders CD4(+) Th cells cytotoxic by activating both perforin- and FasL-pathways.

Koji Eshima1, Sayuri Chiba, Harumi Suzuki, Kenichi Kokubo, Hirosuke Kobayashi, Misao Iizuka, Kazuya Iwabuchi, Nobukata Shinohara.   

Abstract

During viral infection, CD8(+) cytotoxic T lymphocytes (CTL) play a central role to eliminate viruses by destructing virus-infected cells utilizing two cytolytic pathways, i.e., perforin/granzyme pathway and FasL-Fas pathway. It has been shown that effector functions of CTL are critically controlled by two T-box transcription factors, T-bet and eomesodermin (Eomes), although their precise activities in constructing CTL functions are not fully understood. To investigate the functional potency and activities of Eomes, the effects of ectopic expression of Eomes in two terminally differentiated murine CD4(+) Th lines, on their effector functions were analyzed. The results showed that in Eomes-transfected Th hybridoma, cell surface FasL expression upon Con A stimulation was markedly enhanced, although perforin expression was not induced. In normal, non-transformed Th2 cells, introduction of Eomes elicited perforin expression, and also augmented FasL up-regulation. Interestingly, cyotlytic activity of Eomes-transfectant was more efficient than that of perforin-transfected Th2 cells which expressed high levels of perforin and granzyme B mRNA, indicating that Eomes may play additional roles other than preparation of these cytolytic effector molecules. In contrast, stimulation-induced CD154 up-regulation, one of the typical helper T cell characteristics, was repressed in Eomes-transfectant. Collectively, these results suggest that Eomes may not only be involved in perforin/granzyme expression but also play various functions, including FasL up-regulation, to develop the characteristics of CD8(+) CTL. These studies have also suggested that introduction of Eomes alone was sufficient to convert the functions of fully differentiated Th cells toward those of CTL.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22425747     DOI: 10.1016/j.imlet.2012.02.013

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  29 in total

1.  Functional heterogeneity in the CD4+ T cell response to murine γ-herpesvirus 68.

Authors:  Zhuting Hu; Marcia A Blackman; Kenneth M Kaye; Edward J Usherwood
Journal:  J Immunol       Date:  2015-02-06       Impact factor: 5.422

2.  Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia.

Authors:  Susan Johnson; Michael Eller; Jeffrey E Teigler; Sebastien M Maloveste; Bruce T Schultz; Damien Z Soghoian; Richard Lu; Alexander F Oster; Agnès-Laurence Chenine; Galit Alter; Ulf Dittmer; Mary Marovich; Merlin L Robb; Nelson L Michael; Diane Bolton; Hendrik Streeck
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

3.  Vaccination Produces CD4 T Cells with a Novel CD154-CD40-Dependent Cytolytic Mechanism.

Authors:  Rhea N Coler; Thomas Hudson; Sean Hughes; Po-Wei D Huang; Elyse A Beebe; Mark T Orr
Journal:  J Immunol       Date:  2015-08-21       Impact factor: 5.422

4.  Precursors of human CD4+ cytotoxic T lymphocytes identified by single-cell transcriptome analysis.

Authors:  Veena S Patil; Ariel Madrigal; Benjamin J Schmiedel; James Clarke; Patrick O'Rourke; Aruna D de Silva; Eva Harris; Bjoern Peters; Gregory Seumois; Daniela Weiskopf; Alessandro Sette; Pandurangan Vijayanand
Journal:  Sci Immunol       Date:  2018-01-19

5.  Many Th Cell Subsets Have Fas Ligand-Dependent Cytotoxic Potential.

Authors:  Dmitri I Kotov; Jessica A Kotov; Michael F Goldberg; Marc K Jenkins
Journal:  J Immunol       Date:  2018-02-07       Impact factor: 5.422

6.  Memory T Cell Proliferation before Hepatitis C Virus Therapy Predicts Antiviral Immune Responses and Treatment Success.

Authors:  Gema Méndez-Lagares; Ding Lu; Connie Chen; Norah Terrault; Mark R Segal; Mandana Khalili; Alexander Monto; Hui Shen; M Michele Manos; Lewis L Lanier; James C Ryan; Joseph M McCune; Dennis J Hartigan-O'Connor
Journal:  J Immunol       Date:  2017-12-20       Impact factor: 5.422

7.  Differential dependence on nuclear factor-κB-inducing kinase among natural killer T-cell subsets in their development.

Authors:  Haruka Noma; Koji Eshima; Masashi Satoh; Kazuya Iwabuchi
Journal:  Immunology       Date:  2015-06-25       Impact factor: 7.397

8.  Naive CD4+ T Cells Carrying a TLR2 Agonist Overcome TGF-β-Mediated Tumor Immune Evasion.

Authors:  Mohsen Ibrahim; Davide Scozzi; Kelsey A Toth; Donatella Ponti; Daniel Kreisel; Cecilia Menna; Elena De Falco; Antonio D'Andrilli; Erino A Rendina; Antonella Calogero; Alexander S Krupnick; Andrew E Gelman
Journal:  J Immunol       Date:  2017-12-06       Impact factor: 5.422

9.  CD4+ T cells develop antiretroviral cytotoxic activity in the absence of regulatory T cells and CD8+ T cells.

Authors:  Nora Manzke; Ilseyar Akhmetzyanova; Kim J Hasenkrug; Mirko Trilling; Gennadiy Zelinskyy; Ulf Dittmer
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

10.  Inflammation programs self-reactive CD8+ T cells to acquire T-box-mediated effector function but does not prevent deletional tolerance.

Authors:  Stephanie R Jackson; Jinyun Yuan; Melissa M Berrien-Elliott; Collin L Chen; Jennifer M Meyer; Maureen J Donlin; Ryan M Teague
Journal:  J Leukoc Biol       Date:  2014-05-13       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.